Abstract:What We Already Know about This Topic Opioid-induced respiratory depression results in part from direct activation of &mgr;-opioid receptors expressed in the inspiratory rhythm generator located in the ventrolateral medulla, the preBötzinger Complex Respiratory neurons within the medulla also express nicotinic acetylcholine receptors, which are made up of five subunits, arranged symmetrically around a central pore Activation of the nicotinic acetylcholine receptor &agr;4, &agr;7, and &bgr;2 subunits increases respiratory rhythm, whereas activation of the nicotinic acetylcholine receptor &agr;4&bgr;2 or &agr;7 subunits induces analgesia in multiple forms of pain What This Article Tells Us That Is New The nonselective nicotinic acetylcholine receptor agonist nicotine and the &agr;4&bgr;2 nicotinic acetylcholine receptor agonist A85380, but not the &agr;7 nicotinic acetylcholine receptor agonist PNU282987, reversed respiratory depression induced by activation of &mgr;-opioid receptors in rats both in vitro and in vivo Coadministration of A85380 with fentanyl not only markedly reduced respiratory depression and apneas but also enhanced the fentanyl-induced analgesia Background: Opioid analgesics are widely used for treatment of acute, postoperative, and chronic pain. However, activation of opioid receptors can result in severe respiratory depression. There is an unmet clinical need to develop a pharmacologic therapy to counter opioid-induced respiratory depression without interfering with analgesia. Further, additional advances to confront accidental lethal overdose with the use of fentanyl and other opioids are needed. Here, the authors test the hypothesis that activation of nicotinic receptors expressed within respiratory rhythm–generating networks would counter opioid-induced respiratory depression without compromising analgesia. Methods: Respiratory neural discharge was measured using in vitro brainstem–spinal cord and medullary slice rat preparations. In vivo, plethysmographic recording, nociception testing, and righting reflexes were used to examine respiratory ventilation, analgesia, and sedation, respectively. Results: The administration of nicotine, selective &agr;4&bgr;2 nicotinic receptor agonist A85380, but not &agr;7 nicotinic receptor agonist PNU282987, reversed opioid-induced respiratory depression in neonatal pups in vitro and in vivo. In adult rats in vivo, administration of A85380 (0.03 mg/kg), but not PNU282987, provides a rapid and robust reversal of fentanyl-induced decrease in respiratory rate (93.4 ± 33.7% of control 3 min after A85380 vs. 31 ± 20.5% of control after vehicle, n = 8 each, P < 0.001), without marked side effects. The coadministration of A85380 (0.06 mg/kg) with fentanyl or remifentanil markedly reduced respiratory depression and apneas, and enhanced the fentanyl-induced analgesia, as evidenced by increased paw withdrawal latency in Hargreaves plantar test (14.4 ± 2.8 s vs. vehicle: 11.3 ± 2.4 s, n = 8 each, P = 0.013) and decreased formalin-induced nocifensive duration (2.5 ± 2.4 min vs. vehicle: 5.4 ± 2.7 min, n = 8 each, P = 0.029). Conclusions: The novel strategy of targeting &agr;4&bgr;2 nicotinic acetylcholine receptors has the potential for advancing pain control and reducing opioid-induced respiratory depression and overdose.

[Inhibitory Effect of 6 Beta-Acetoxy Nortropane on Respiration].

[Effects of Inhaled Nitric Oxide on Rabbits with Meconium Aspiration Pneumonia].

Pharmacological actions of a new -adrenoceptor agonist, MJ-9184-1, in anaesthetized cats

Changes in pontine and preBötzinger/Bötzinger complex neuronal activity during remifentanil-induced respiratory depression in decerebrate dogs

Effect of SR-140333,a Neurokinin-1 Receptor Antagonist,on Airway Reactivity to Methacholine in Sedated Rats

Respiratory effects of kynurenic acid microinjected into the ventromedullary surface of the rat

Countering Opioid-induced Respiratory Depression in Male Rats with Nicotinic Acetylcholine Receptor Partial Agonists Varenicline and ABT 594.

Opioid‐Induced Respiratory Depression (OIRD) in C57BL/6J (B6) Mice is Mitigated by Prefrontal Cortex Neostigmine Administration

Role of the medial area of the nucleus retrofacialis in morphine-induced respiratory depression in rabbits

Study on the effects of six intravenous anesthetic agents on regional ventricular function in dogs (thiopental, etomidate, propofol, fentanyl, sufentanil, alfentanil)

Tuning density profiles and mobility of inhomogeneous fluids.

EFFECTS OF ATRIAL-NATRIURETIC-FACTOR ON BLOOD-FLOW DISTRIBUTION AND VASCULAR-RESISTANCE IN CONSCIOUS DOGS

Activating α4β2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats.

Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing

Activating &agr;4&bgr;2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats

Atrial Natriuretic Factor-Induced Systemic Vasoconstriction in Conscious Dogs, Rats, and Monkeys.

Efficacy of Nalmefene Antagonizing Postoperative Respiratory Depression Induced by Opioids:A Multicenter,randomized,double-Blind,positive Drug-Controlled Study

Reversal of propofol-induced depression of the hypoxic ventilatory response by BK-channel blocker ENA-001: a randomized controlled trial

Volatile anesthetics maintain tidal volume and minute ventilation to a greater degree than propofol under spontaneous respiration

Increase in nurse numbers linked to better patient survival rates in ICU.

Repeated Loss of Consciousness in a Young Woman: A Suspicious SMAD3 Mutation Underlying Spontaneous Coronary Artery Dissection.